192 related articles for article (PubMed ID: 20081872)
1. Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol.
Zhang XQ; Huang XF; Mu SJ; An QX; Xia AJ; Chen R; Wu DC
Asian J Androl; 2010 May; 12(3):390-9. PubMed ID: 20081872
[TBL] [Abstract][Full Text] [Related]
2. (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer.
Xu L; Yang D; Wang S; Tang W; Liu M; Davis M; Chen J; Rae JM; Lawrence T; Lippman ME
Mol Cancer Ther; 2005 Feb; 4(2):197-205. PubMed ID: 15713891
[TBL] [Abstract][Full Text] [Related]
3. Gossypol induces apoptosis in human PC-3 prostate cancer cells by modulating caspase-dependent and caspase-independent cell death pathways.
Zhang M; Liu H; Tian Z; Griffith BN; Ji M; Li QQ
Life Sci; 2007 Jan; 80(8):767-74. PubMed ID: 17156797
[TBL] [Abstract][Full Text] [Related]
4. Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo.
Zhang X; Hu X; Mu S; Zhan Y; An Q; Liu Z; Huang X
Mol Med Rep; 2014 Sep; 10(3):1184-94. PubMed ID: 25060748
[TBL] [Abstract][Full Text] [Related]
5. (-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.
Pang X; Wu Y; Wu Y; Lu B; Chen J; Wang J; Yi Z; Qu W; Liu M
Mol Cancer Ther; 2011 May; 10(5):795-805. PubMed ID: 21372225
[TBL] [Abstract][Full Text] [Related]
6. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.
Meng Y; Tang W; Dai Y; Wu X; Liu M; Ji Q; Ji M; Pienta K; Lawrence T; Xu L
Mol Cancer Ther; 2008 Jul; 7(7):2192-202. PubMed ID: 18645028
[TBL] [Abstract][Full Text] [Related]
7. [Difference of gene expression profile in human gastric cancer grafted onto nude mice treated with WCA].
Zhao AG; Yang JK; You SF; Li T; Zhao HL; Gu Y; Tang LD
Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2028-36. PubMed ID: 18161298
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells.
Oliver CL; Bauer JA; Wolter KG; Ubell ML; Narayan A; O'Connell KM; Fisher SG; Wang S; Wu X; Ji M; Carey TE; Bradford CR
Clin Cancer Res; 2004 Nov; 10(22):7757-63. PubMed ID: 15570010
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
Lu YY; Jing DD; Xu M; Wu K; Wang XP
World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
[TBL] [Abstract][Full Text] [Related]
10. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
[TBL] [Abstract][Full Text] [Related]
11. Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.
Lian J; Ni Z; Dai X; Su C; Smith AR; Xu L; He F
Mol Cancer Ther; 2012 Feb; 11(2):416-26. PubMed ID: 22188816
[TBL] [Abstract][Full Text] [Related]
12. Terrestrosin D, a steroidal saponin from Tribulus terrestris L., inhibits growth and angiogenesis of human prostate cancer in vitro and in vivo.
Wei S; Fukuhara H; Chen G; Kawada C; Kurabayashi A; Furihata M; Inoue K; Shuin T
Pathobiology; 2014; 81(3):123-32. PubMed ID: 24642631
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
Lin J; Wu Y; Yang D; Zhao Y
Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
[TBL] [Abstract][Full Text] [Related]
14. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction.
Xiao D; Lew KL; Kim YA; Zeng Y; Hahm ER; Dhir R; Singh SV
Clin Cancer Res; 2006 Nov; 12(22):6836-43. PubMed ID: 17121905
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.
Huang YW; Wang LS; Chang HL; Ye W; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2006; 26(3A):1925-33. PubMed ID: 16827126
[TBL] [Abstract][Full Text] [Related]
16. AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model.
McGregor N; Patel L; Craig M; Weidner S; Wang S; Pienta KJ
J Cell Biochem; 2010 Aug; 110(5):1187-94. PubMed ID: 20589722
[TBL] [Abstract][Full Text] [Related]
17. SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway.
Xie G; Zhu X; Li Q; Gu M; He Z; Wu J; Li J; Lin Y; Li M; She Z; Yuan J
Br J Pharmacol; 2010 Feb; 159(3):689-97. PubMed ID: 20128807
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines.
Coyle T; Levante S; Shetler M; Winfield J
J Neurooncol; 1994; 19(1):25-35. PubMed ID: 7815102
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Bcl-2, Src, and ERα in gossypol-mediated growth inhibition and apoptosis in human uterine leiomyoma and myometrial cells.
ZHU Y; XIE SW; ZHANG JF; ZHANG TT; ZHOU JY; CAO Y; CAO L
Acta Pharmacol Sin; 2010 Dec; 31(12):1593-603. PubMed ID: 21102482
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 mediated modulation of vascularization in prostate cancer xenografts.
Sakai Y; Goodison S; Kusmartsev S; Fletcher B; Eruslanov E; Cao W; Porvasnik S; Namiki K; Anai S; Rosser CJ
Prostate; 2009 Apr; 69(5):459-70. PubMed ID: 19107861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
